Rural Medicine A Tough Road To Travel – PharmAsia Summit
This article was originally published in PharmAsia News
Many drug companies make it policy to try and reach all possible patients, but struggle to understand complex distribution systems in countries like China to reach low-income and rural patients.
You may also be interested in...
Sandoz will commercialize TLC’s liposomal amphotericin B product, a generic of Gilead’s AmBisome, in the U.S. and EU.
Taiwan Liposome Co. Ltd. has the funds and team to reach outside of its base in Taiwan to turn old drugs into new products and is looking for opportunities at Asia-specific product applications.